BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34225090)

  • 1. Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China.
    Wei J; Wu M; Liu J; Wang X; Xia P; Peng L; Huang Y; Liu C; Xia Z; Chen C; Zhao Y
    Breast; 2021 Oct; 59():102-109. PubMed ID: 34225090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China.
    Tang ML; Li YQ; Chen X; Lin H; Jiang ZC; Gu DL; Chen X; Tang CX; Xie ZQ
    Med Sci Monit; 2021 Jan; 27():e929783. PubMed ID: 33388738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
    Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
    Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
    Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients.
    Brown JE; Cook RJ; Lipton A; Coleman RE
    Clin Cancer Res; 2012 Nov; 18(22):6348-55. PubMed ID: 22952345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 8. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study.
    Tian J; Yuan X; Xiao J; Zhong Q; Yang C; Liu B; Cai Y; Lu Z; Wang J; Wang Y; Liu S; Cheng B; Wang J; Zhang M; Wang L; Niu S; Yao Z; Deng X; Zhou F; Wei W; Li Q; Chen X; Chen W; Yang Q; Wu S; Fan J; Shu B; Hu Z; Wang S; Yang XP; Liu W; Miao X; Wang Z
    Lancet Oncol; 2020 Jul; 21(7):893-903. PubMed ID: 32479790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.
    Hariyanto TI; Japar KV; Kwenandar F; Damay V; Siregar JI; Lugito NPH; Tjiang MM; Kurniawan A
    Am J Emerg Med; 2021 Mar; 41():110-119. PubMed ID: 33418211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.
    Yitao Z; Mu C; Ling Z; Shiyao C; Jiaojie X; Zhichong C; Huajing P; Maode O; Kanglin C; Mao OY; Xiaoneng M; Weijie Z
    Curr Med Res Opin; 2021 Mar; 37(3):385-391. PubMed ID: 33459077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of COVID-19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China.
    Liu J; Liu Z; Jiang W; Wang J; Zhu M; Song J; Wang X; Su Y; Xiang G; Ye M; Li J; Zhang Y; Shen Q; Li Z; Yao D; Song Y; Yu K; Luo Z; Ye L
    Clin Respir J; 2021 Mar; 15(3):293-309. PubMed ID: 33090710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
    Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
    Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
    Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
    Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: A retrospective analysis.
    Zhang XB; Hu L; Ming Q; Wei XJ; Zhang ZY; Chen LD; Wang MH; Yao WZ; Huang QF; Ye ZQ; Cai YQ; Zeng HQ
    PLoS One; 2021; 16(1):e0246030. PubMed ID: 33507974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
    Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
    Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.
    Dong X; Sun L; Li Y
    Int J Med Sci; 2020; 17(14):2225-2231. PubMed ID: 32922185
    [No Abstract]   [Full Text] [Related]  

  • 18. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.
    Vidal-Cevallos P; Higuera-De-La-Tijera F; Chávez-Tapia NC; Sanchez-Giron F; Cerda-Reyes E; Rosales-Salyano VH; Servin-Caamaño A; Vázquez-Medina MU; Méndez-Sánchez N
    Ann Hepatol; 2021; 24():100338. PubMed ID: 33647501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
    Yarza R; Bover M; Paredes D; López-López F; Jara-Casas D; Castelo-Loureiro A; Baena J; Mazarico JM; Folgueira MD; Meléndez-Carmona MÁ; Reyes A; Lumbreras C; Paz-Ares L; Díaz-Pedroche C; Gómez-Martín C
    Eur J Cancer; 2020 Aug; 135():242-250. PubMed ID: 32586724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Guo J; Zhou B; Zhu M; Yuan Y; Wang Q; Zhou H; Wang X; Lv T; Li S; Liu P; Yang Y; He P; Zhang P
    Epidemiol Infect; 2020 Oct; 148():e241. PubMed ID: 32998791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.